Literature DB >> 22345588

Defibrotide: a Swiss Army knife intervention in the battle against cerebral malaria.

Julie M Moore, John W Avery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22345588      PMCID： PMC4811596          DOI： 10.1161/ATVBAHA.111.242776

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  32 in total

1.  The effect of leukocyte elastase on tissue factor pathway inhibitor.

Authors:  D A Higuchi; T C Wun; K M Likert; G J Broze
Journal:  Blood       Date:  1992-04-01       Impact factor: 22.113

2.  Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor.

Authors:  G E Grau; H Heremans; P F Piguet; P Pointaire; P H Lambert; A Billiau; P Vassalli
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

Review 3.  Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.

Authors:  Sarah J Higgins; Kevin C Kain; W Conrad Liles
Journal:  Expert Rev Anti Infect Ther       Date:  2011-09       Impact factor: 5.091

Review 4.  Use of defibrotide in the treatment and prevention of veno-occlusive disease.

Authors:  Paul Richardson; Erica Linden; Carolyn Revta; Vincent Ho
Journal:  Expert Rev Hematol       Date:  2009-08       Impact factor: 2.929

5.  Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes.

Authors:  I M B Francischetti; K B Seydel; R Q Monteiro; R O Whitten; C R Erexson; A L L Noronha; G R Ostera; S B Kamiza; M E Molyneux; J M Ward; T E Taylor
Journal:  J Thromb Haemost       Date:  2006-09-26       Impact factor: 5.824

Review 6.  The protein C pathway.

Authors:  Charles T Esmon
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

7.  Malaria-induced murine pregnancy failure: distinct roles for IFN-gamma and TNF.

Authors:  Jayakumar S Poovassery; Demba Sarr; Geoffrey Smith; Tamas Nagy; Julie M Moore
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

8.  Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells.

Authors:  A Falanga; A Vignoli; M Marchetti; T Barbui
Journal:  Leukemia       Date:  2003-08       Impact factor: 11.528

9.  Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation.

Authors:  Frank Niessen; Florence Schaffner; Christian Furlan-Freguia; Rafal Pawlinski; Gourab Bhattacharjee; Jerold Chun; Claudia K Derian; Patricia Andrade-Gordon; Hugh Rosen; Wolfram Ruf
Journal:  Nature       Date:  2008-02-27       Impact factor: 49.962

10.  Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study.

Authors:  Andrea L Conroy; Happy Phiri; Michael Hawkes; Simon Glover; Mac Mallewa; Karl B Seydel; Terrie E Taylor; Malcolm E Molyneux; Kevin C Kain
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240
View more
  2 in total

1.  Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide.

Authors:  Julia Martinez-Sanchez; Hannah Hamelmann; Marta Palomo; Enrique Mir; Ana Belen Moreno-Castaño; Sergi Torramade; Montserrat Rovira; Ginés Escolar; Steffen Cordes; Martina Kalupa; Sarah Mertlitz; Katarina Riesner; Enric Carreras; Olaf Penack; Maribel Diaz-Ricart
Journal:  Front Immunol       Date:  2019-10-09       Impact factor: 7.561

2.  Tempol, an intracellular antioxidant, inhibits tissue factor expression, attenuates dendritic cell function, and is partially protective in a murine model of cerebral malaria.

Authors:  Ivo M B Francischetti; Emile Gordon; Bruna Bizzarro; Nidhi Gera; Bruno B Andrade; Fabiano Oliveira; Dongying Ma; Teresa C F Assumpção; José M C Ribeiro; Mirna Pena; Chen-Feng Qi; Ababacar Diouf; Samuel E Moretz; Carole A Long; Hans C Ackerman; Susan K Pierce; Anderson Sá-Nunes; Michael Waisberg
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.